156 related articles for article (PubMed ID: 38015219)
41. Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan.
Nishimura Y; Matsuura M; Terada N; Nagao S; Shimada H; Isoyama K; Tamate M; Iwasaki M; Saito T
BMC Public Health; 2023 Mar; 23(1):473. PubMed ID: 36906527
[TBL] [Abstract][Full Text] [Related]
42. HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
Aasbø G; Tropè A; Nygård M; Christiansen IK; Baasland I; Iversen GA; Munk AC; Christiansen MH; Presthus GK; Undem K; Bjørge T; Castle PE; Hansen BT
Br J Cancer; 2022 Nov; 127(10):1816-1826. PubMed ID: 35995936
[TBL] [Abstract][Full Text] [Related]
43. Home Self-Collection by Mail to Test for Human Papillomavirus and Sexually Transmitted Infections.
Des Marais AC; Zhao Y; Hobbs MM; Sivaraman V; Barclay L; Brewer NT; Smith JS
Obstet Gynecol; 2018 Dec; 132(6):1412-1420. PubMed ID: 30399091
[TBL] [Abstract][Full Text] [Related]
44. A Randomized Trial of Human Papillomavirus Self-Sampling as an Intervention to Promote Cervical Cancer Screening Among Women With HIV.
Murphy J; Mark H; Anderson J; Farley J; Allen J
J Low Genit Tract Dis; 2016 Apr; 20(2):139-44. PubMed ID: 27015260
[TBL] [Abstract][Full Text] [Related]
45. A conjoint analysis study on self-sampling for human papillomavirus (HPV) testing characteristics among black women in Indiana.
Biederman E; Champion V; Zimet G
BMC Womens Health; 2020 Mar; 20(1):55. PubMed ID: 32192493
[TBL] [Abstract][Full Text] [Related]
46. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
[TBL] [Abstract][Full Text] [Related]
47. Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening.
Costa S; Verberckmoes B; Castle PE; Arbyn M
Br J Cancer; 2023 Mar; 128(5):805-813. PubMed ID: 36517552
[TBL] [Abstract][Full Text] [Related]
48. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
49. Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening.
Liebermann E; Fontenot HB; Lim E; Matsunaga M; Zimet G; Allen JD
J Obstet Gynecol Neonatal Nurs; 2023 Sep; 52(5):364-373. PubMed ID: 37355248
[TBL] [Abstract][Full Text] [Related]
50. Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches.
Ivanus U; Jerman T; Fokter AR; Takac I; Prevodnik VK; Marcec M; Gajsek US; Pakiz M; Koren J; Celik SH; Kramberger KG; Klopcic U; Kavalar R; Zatler SS; Kuzmanov BG; Florjancic M; Nolde N; Novakovic S; Poljak M; Zakelj MP
Radiol Oncol; 2018 Sep; 52(4):399-412. PubMed ID: 30216191
[TBL] [Abstract][Full Text] [Related]
51. Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial.
Sewali B; Okuyemi KS; Askhir A; Belinson J; Vogel RI; Joseph A; Ghebre RG
Cancer Med; 2015 Apr; 4(4):620-31. PubMed ID: 25653188
[TBL] [Abstract][Full Text] [Related]
52. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
[TBL] [Abstract][Full Text] [Related]
53. Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
Gibson-Helm M; Slater T; MacDonald EJ; Stevenson K; Adcock A; Geller S; Parag V; Lambert C; Bennett M; Hibma M; Sykes P; Saville M; Hawkes D; Stanton JA; Clueard MA; Jelley G; Lawton B
PLoS One; 2023; 18(3):e0280643. PubMed ID: 36952546
[TBL] [Abstract][Full Text] [Related]
54. Offering self-sampling to cervical screening non-attenders in primary care.
Lim AW; Hollingworth A; Kalwij S; Curran G; Sasieni P
J Med Screen; 2017 Mar; 24(1):43-49. PubMed ID: 27235844
[TBL] [Abstract][Full Text] [Related]
55. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
Aarnio R; Östensson E; Olovsson M; Gustavsson I; Gyllensten U
BMC Cancer; 2020 Jul; 20(1):645. PubMed ID: 32660432
[TBL] [Abstract][Full Text] [Related]
56. Co-creation of human papillomavirus self-sampling delivery strategies for cervical cancer screening in rural Zimbabwe: nominal group technique.
Dzobo M; Dzinamarira T; Murewanhema G; Chishapira T; Dube Mandishora RS; Fitzpatrick M; Mashamba-Thompson T
Front Public Health; 2023; 11():1275311. PubMed ID: 38035305
[TBL] [Abstract][Full Text] [Related]
57. Automated Opt-Out vs Opt-In Patient Outreach Strategies for Breast Cancer Screening: A Randomized Clinical Trial.
Marcotte LM; Deeds S; Wheat C; Gunnink E; Gray K; Rojas J; Finch C; Nelson K; Reddy A
JAMA Intern Med; 2023 Nov; 183(11):1187-1194. PubMed ID: 37695621
[TBL] [Abstract][Full Text] [Related]
58. Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials.
Di Gennaro G; Licata F; Trovato A; Bianco A
Front Public Health; 2022; 10():1003461. PubMed ID: 36568753
[TBL] [Abstract][Full Text] [Related]
59. Effects of Message Framing on Cervical Cancer Screening Knowledge and Intentions Related to Primary HPV Testing.
Ogden SN; Leskinen EA; Sarma EA; Wainwright JV; Rendle KA
Cancer Prev Res (Phila); 2021 Sep; 14(9):839-844. PubMed ID: 33846214
[TBL] [Abstract][Full Text] [Related]
60. Mail-Based Self-Sampling to Complete Colorectal Cancer Screening: Accelerating Colorectal Cancer Screening and Follow-up Through Implementation Science.
Gupta S; Barnes A; Brenner AT; Campbell J; Davis M; English K; Hoover S; Kim K; Kobrin S; Lance P; Mishra SI; Oliveri JM; Reuland DS; Subramanian S; Coronado GD
Prev Chronic Dis; 2023 Dec; 20():E112. PubMed ID: 38060411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
